FDA inspection
TWI Pharmaceuticals, Inc. - Zhongli Plant: FDA inspection ending Jul 27, 2007
FDA inspection 491762 · No Action Indicated (NAI) · Taoyuan City
Key facts
| Inspection ID | 491762 |
|---|---|
| Firm | TWI Pharmaceuticals, Inc. - Zhongli Plant |
| FEI number | 3005674517 |
| Address | Zhongli Industrial Zone, No. 3-1 Ziqiang 4th Rd.; Zhongli Dist. |
| City | Taoyuan City |
| Fiscal year | 2007 |
| Inspection end date | Jul 27, 2007 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data